Haiti vs Kazakhstan: Treatment success rate for patients treated for MDR-TB
Haiti
85.0%
in 2022
Kazakhstan
84.0%
in 2022
Haiti rank
35th
Kazakhstan rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Haiti
- Kazakhstan
How they compare
Haiti currently reports 85.0% against 84.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 2 times across 16 shared years of data; in 2006 it was Haiti ahead.
Haiti ranks 35th and Kazakhstan ranks 38th of 163 countries.
Across the 3 decades both report, Haiti averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | Haiti | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.3% | 76.0% | 5.7% | Kazakhstan |
| 2010s | 80.2% | 76.4% | 3.8% | Haiti |
| 2020s | 85.0% | 80.7% | 4.3% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Haiti or Kazakhstan?
- Haiti, at 85.0% against 84.0% in Kazakhstan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Haiti and Kazakhstan?
- 1.0%, with Haiti ahead.
- How many years of comparable data are there for Haiti and Kazakhstan?
- 16 years are reported by both, from 2006 to 2022.
- How do Haiti and Kazakhstan rank globally for treatment success rate for patients treated for mdr-tb?
- Haiti ranks 35th and Kazakhstan ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.